Shenzhen Mindray Stock Hits Day Low Amid Price Pressure, Closes at CNY 169.52

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. experienced a significant decline today, with the stock dropping by 4.82% and reaching an intraday low of CNY 169.52. This performance is notably below the China Shanghai Composite, which fell by 1.24% on the same day. Over the past week, Shenzhen Mindray has seen a 6.12% decrease, while its monthly performance reflects an 8.75% decline. The company's financial metrics indicate ongoing challenges, with a net profit of CNY 4,940.88 million showing a decrease of 33.91%. Additionally, net sales for the half-year period have contracted by 12.58%, contributing to a year-to-date performance of -10.99%. Over the last year, the stock has underperformed significantly, with a decline of 32.33%, contrasting sharply with the 16.08% gain of the China Shanghai Composite. Shenzhen Mindray's market capitalization stands at CNY 225,235 million, and it currently has a price-to-earnings ratio of 31.00. The company also offers a dividend yield of 2.49%, although its long-term performance remains below par, with a three-year decline of 43.29%.